Furthermore, antagonist effect exists between SOD and NF-κB. Transactivator of transcription (Tat)-SOD protein can hinder NF-κB activation, defending the oxidation-driven atherosclerosis in HUVECs [82]. This evidence concerns the gene TAT and atherosclerosis.